ILLIT's Moca Halts Activities 10 Days Before Comeback to Focus on Treatment [Full Text]

*This content was translated by AI.

ILLIT member Moca will halt activities due to health issues 10 days before the comeback.

Agency BillifLab announced on the 20th via the fan platform Weverse, "Moca recently received medical treatment due to health abnormalities and was advised by medical professionals to undergo continuous treatment and sufficient rest."

It further stated, "While the artist's will to continue activities is strong, the agency has determined that prioritizing the artist's recovery and focusing on treatment for the time being is necessary. Accordingly, Moca will unavoidably be unable to participate in the scheduled ILLIT activities for the time being."

The agency added, "Even if it takes some time, we plan to re-announce the resumption of activities after carefully reviewing the artist's recovery progress. We will do our utmost to support Moca so she can appear before fans again in good health."

ILLIT is set to release their 4th mini-album 'MAMIHLAPINATAPAI' on the 30th.

◆ Full official statement from BillifLab below.

Hello, this is BillifLab.

We are providing an update regarding ILLIT member Moca's schedule.

Moca recently received medical treatment due to health abnormalities and was advised by medical professionals to undergo continuous treatment and sufficient rest.

While the artist's will to continue activities is strong, the agency has determined that prioritizing the artist's recovery and focusing on treatment for the time being is necessary.

Accordingly, we are informing you that Moca will unavoidably be unable to participate in the scheduled ILLIT activities for the time being.

Even if it takes some time, we plan to re-announce the resumption of activities after carefully reviewing the artist's recovery progress.

We will do our utmost to support Moca so she can appear before fans again in good health.

We kindly ask all GRIFFINS to send warm support and encouragement.

Thank you.

<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>

*This content was translated by AI.